Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
by Mateos, Maria-Victoria (Author)
, Blacklock, Hilary (Author)
, Schjesvold, Fredrik (Author)
, Oriol, Albert (Author)
, Simpson, David (Author)
, George, Anupkumar (Author)
, Goldschmidt, Hartmut (Author)
, Larocca, Alessandra (Author)
, Chanan-Khan, Asher A. A. (Author)
, Sherbenou, Daniel (Author)
, Avivi, Irit (Author)
, Benyamini, Noam (Author)
, Iida, Shinsuke (Author)
, Matsumoto, Morio (Author)
, Suzuki, Kenshi (Author)
, Ribrag, Vincent (Author)
, Usmani, Saad Z. (Author)
, Jagannath, Sundar (Author)
, Ocio, Enrique M (Author)
, Rodriguez-Otero, Paula (Author)
, San-Miguel, Jesús F. (Author)
, Kher, Uma (Author)
, Farooqui, Mohammed (Author)
, Liao, Jason (Author)
, Marinello, Patrizia (Author)
, Lonial, Sagar (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource